Summit Securities Group’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$79.2K	Buy	+8,531	New	+$79.2K	0.02%	302
2025 Q1	–	Sell	-1,311	Closed	-$11.2K	–	861
2024 Q4	$11.2K	Buy	+1,311	New	+$11.2K	﹤0.01%	317